Gene-Disorder Association · Article
Gene
PPARG Peroxisome Proliferator Activated Receptor Gamma
×
First reported
1950
Supporting publications
14
Approved treatment annotated
Association Review
In brief The association between PPARG (Peroxisome Proliferator Activated Receptor Gamma) and Coronary Artery Anomaly is reported, supported by a single source.
Sources
1
Clinical variants
0
Symptoms
7
Compounds
1
Trials
3 of 36 via PPARG compounds
Publications
14
Contents
01
At a glance
Association overview A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access 02
Provenance
Evidence and sources 1 source
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access 2 source summaries
A gene summary alongside the source descriptions it was distilled from.
Request access 04
Coronary Artery Anomaly
The disorder 21 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access 05
Genomic context
Regulatory context 1 regulatory element
GeneHancer regulatory elements for the pair, with coordinates, score, element type and supporting literature.
Request access 06
Interventions
Therapeutics 1 compound or drug
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access 07
Human studies
Clinical trials 36 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access 14 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access 09
Provenance
References & sources 15 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access 
